2-Chloro-1,3-Thiazole-5-Carboxaldehyde

2-Chloro-1,3-thiazole-5-carboxaldehyde is charged into a jacketed 316L stainless steel reactor at a typical batch scale of 500–2,500 kg, pre-dried to a moisture content below 0.15 wt% (Karl Fischer titration, ASTM E203) to suppress hydrate formation that interferes with downstream anhydrous coupling. The aldehyde is dissolved in tetrahydrofuran (THF, water content ≤ 50 ppm) at 15–20°C under a nitrogen blanket (oxygen ≤ 0.5 vol%) to limit autoxidation to the corresponding carboxylic acid, a by-product that must remain below 0.8 area% by GC-FID for subsequent neonicotinoid intermediate qualification. A methanolic solution of sodium borohydride (1.12–1.18 molar equivalents relative to aldehyde) stabilized with sodium hydroxide (0.1 M) is metered into the vessel at a rate maintaining an internal temperature between −2°C and +3°C; exotherm excursion beyond 8°C triggers a safety interlock that diverts the feed stream. The reduction to 2-chloro-5-hydroxymethyl-1,3-thiazole proceeds with a typical conversion exceeding 98.5 mole%, after which the reaction mass is quenched with aqueous ammonium chloride (15 wt%, pH 5.8–6.2) and the organic phase subjected to a triple water wash to achieve residual boron levels below 5 ppm as measured by ICP-OES. The crude alcohol is then chlorinated using thionyl chloride (1.25–1.35 eq) in dichloromethane containing 0.3–0.5 wt% pyridine as acid scavenger, keeping the temperature at 0–10°C; the resulting 2-chloro-5-chloromethyl-1,3-thiazole is fractionally distilled under reduced pressure (10–15 mbar, overhead temperature 78–84°C) to obtain the pesticide-grade intermediate with a purity target of ≥ 97.0% (GC area normalization) and residual aldehyde capped at ≤ 0.5 area%. The finished active substance clothianidin, synthesized from this intermediate, must comply with FAO Specification 471/TC for technical material and EPA 40 CFR § 180.586 tolerance residues in raw agricultural commodities; accordingly, downstream process audits enforce absence of genotoxic impurities per ICH M7 with a threshold of toxicological concern limit not exceeding 1.5 µg/day for the aldehyde-derived alkyl chloride precursors.

What Limits the Catalytic Cycle When the Aldehyde Participates in Stille Cross-Couplings for Antiviral Scaffolds?

In medicinal chemistry routes targeting thiazole-modified non-nucleoside reverse transcriptase inhibitors, the chlorine atom at C-2 and the aldehyde at C-5 are orthogonal handles that mandate a strict sequencing of palladium-catalyzed transformations. When 2-chloro-1,3-thiazole-5-carboxaldehyde is first subjected to Stille coupling with a stannylated pyrimidine partner (e.g., 2-(tributylstannyl)pyrimidine, 1.05 eq) using Pd(PPh₃)₄ (2.5–3.0 mol%) in degassed dioxane at 95°C for 14–18 hours, the aldehyde remains intact while the chloro substituent activates the oxidative insertion. The crude coupled aldehyde is isolated by flash chromatography (heptane/ethyl acetate 3:1) to a purity of ≥ 95 area% and then advanced to reductive amination with (S)-tetrahydrofuran-3-amine hydrochloride (1.15 eq) in the presence of sodium triacetoxyborohydride (1.4 eq) in 1,2-dichloroethane containing acetic acid (0.2 eq) at 20–25°C. A critical operational boundary arises from the residual palladium content in the aldehyde intermediate: levels exceeding 50 ppm (quantified by AAS after microwave digestion) poison the subsequent hydrogenation step used for debenzylation of a protecting group elsewhere in the molecule, requiring an additional scavenging treatment with Si-Thiol functionalised silica gel (10 wt% loading relative to substrate) that lengthens the campaign by 8 hours. The final API (a candidate designated under an open Investigational New Drug application) must respect ICH Q3D elemental impurity limits for Pd (oral permitted daily exposure ≤ 100 µg/day) and for chloroalkane genotoxicity flags evaluated via Ames test per OECD TG 471. Production-scale campaigns on a 0.8–1.2 kmol input routinely encounter a batch-to-batch colour variance in the Stille adduct (light yellow to dark amber) that correlates with residual triphenylphosphine oxide carryover and is monitored by a forced degradation stability protocol at 40°C/75% RH for 14 days per ICH Q1A(R2). Processing on a multi-purpose cGMP-compliant suite requires dedicated glass-lined vessels (2,000 L) pre-cleaned per a validated CIP procedure with 1% citric acid rinse to sequester iron traces that accelerate aldehyde oxidation below pH 4.5.

When the thiazole aldehyde is employed as a heterocyclic dienophile in inverse-electron-demand Diels-Alder cycloadditions with electron-rich dienes, the chloro substituent exerts a measurable rate-retarding effect through inductive withdrawal, requiring extended reaction times (48–72 hours) or microwave irradiation (120°C, 100 W, closed vessel) to achieve > 80% conversion. Industrial implementation of this chemistry for fused pyridothiazole targets relies on flow reactors (PFA coil, 0.8 mm ID, residence time 12 min) that safely contain pressures up to 20 bar and suppress the thermal decomposition of the aldehyde that begins to accelerate at >135°C (DSC onset, 10°C/min scan rate). Published data for continuous-flow processing of this specific aldehyde at multi-tonne scale are limited; however, pilot campaigns document that all process streams must be analysed for chloroform-soluble oligomeric by-products by GPC to prevent downstream fouling of thin-film evaporators used for solvent recovery.

SDHI Fungicide Core: Acylation Protocols and the Emergence of a Non-Isolable Intermediate

Construction of the thiazole carboxamide backbone central to succinate dehydrogenase inhibitor (SDHI) fungicides begins with the oxidative transformation of the aldehyde into 2-chlorothiazole-5-carboxylic acid. Sodium chlorite (2.0–2.3 eq, technical grade) in acetonitrile/water (4:1 v/v) buffered with monobasic sodium phosphate (0.6 M) at 0–5°C selectively converts the aldehyde, while the C-2 chlorine remains untouched below 10°C; the resulting acid precipitates upon acidification to pH 2.0 with 6 N HCl and is isolated via a centrifuge with a cake wash protocol that keeps residual chloride ion below 200 ppm to avoid catalyst deactivation in the subsequent amide coupling. Direct coupling of the acid with 2-methyl-4-(trifluoromethyl)aniline employs 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU, 1.1 eq) and N,N-diisopropylethylamine (3.0 eq) in dimethylformamide at −10°C to pre-form the active ester over 45 min before amine addition. This order of addition is mandatory: reverse addition of amine first triggers a competitive nucleophilic aromatic substitution at the C-2 chloro position, generating a difunctional impurity that co-elutes with the desired amide under standard reversed-phase HPLC conditions (C18, MeCN/water 65:35, 0.1% TFA, retention time difference < 0.15 min). Purification of the penultimate anilide is accomplished by recrystallization from toluene/methylcyclohexane (1:2), where a cooling rate of 0.2°C/min is critical to maintain a polymorph (Form II) with acceptable powder flowability (Carr index 18, determined per ASTM D6393) during downstream formulation into water-dispersible granules. The final SDHI active ingredient is governed by OECD Series on Testing and Assessment No. 506 for low-level metabolite identification, and any carryover of the chlorothiazole aldehyde precursor must be controlled below 0.1 wt% in the technical concentrate because the free aldehyde reacts exothermically with sulfosuccinate wetting agents commonly used in co-formulated suspension concentrates, causing a viscosity spike of > 1,200 mPa·s within 72 h of ambient storage.

Incorporation of the thiazole aldehyde into bis-heterocyclic ketone photoinitiators proceeds via a solvent-free Knoevenagel condensation with an active methylene compound (e.g., 1,3-diethyl-2-thiobarbituric acid) in the presence of a catalytic amount of piperidine (0.03 eq) and benzoic acid (0.02 eq) at 70–75°C under reduced pressure (200 mbar) to remove water azeotropically. The melt crystallizes on cooling to afford a crystalline electron-acceptor chromophore; residual aldehyde in the product must not exceed 0.3 area% because it functions as a radical scavenger during UV-curing of acrylated oligomers, diminishing the gel content of the cured film measured according to ASTM D6248-98 by 4–7 percentage points. The photocured clear coats are assessed for haze (< ASTM D1003) and yellowness index (< ASTM E313) after QUV-B aging, with failure defined as a ΔYI exceeding 2.5 after 1,000 h.

When a peptide-drug conjugate demands a traceless linker cleavable under mildly acidic conditions, the thiazole-5-carboxaldehyde serves as the orthogonally addressable anchor point for an oxime ether that remains stable at physiological pH 7.4 but undergoes accelerated hydrolysis at endosomal pH 5.0–5.5. The conjugation protocol on a 50 g batch of aminooxyacetyl-functionalized trastuzumab Fab´ fragment operates at 4°C in sodium acetate buffer (50 mM, pH 4.7) with 2.5 molar equivalents of the mPEG₄-thiazole aldehyde carrying the cytotoxic payload; the reaction is arrested after 16 hours by buffer exchange into pH 6.0 histidine/sucrose. Unreacted aldehyde residues, which can covalently cap lysine side chains under storage, are scavenged by the addition of 5 mM ethanolamine and monitored by HIC-HPLC (TSKgel Butyl-NPR, 1.7 M – 0.8 M (NH₄)₂SO₄ gradient). Drug-to-antibody ratio consistency (DAR 3.8 ± 0.3) requires the aldehyde intermediate to be stored under argon at −20°C in sealed amber vials because exposure to ambient fluorescent light for 48 hours generates an isomeric aldehyde hydrate that interferes with oxime ligation kinetics, shifting the apparent second-order rate constant downward by 40–60% (measured by stopped-flow UV at 280 nm). The final lyophilized conjugate is released per Ph. Eur. general chapter 2.6.15 for prekallikrein activator evaluation and must meet a specification of free thiazole-related small molecules not exceeding 50 ng/mg of protein.

When a Metal-Organic Framework Node Requires Precise Heteroatom Spacing: A Ditopic Linker Situation

Condensation of 2-chloro-1,3-thiazole-5-carboxaldehyde with 4,4´-diaminostilbene dihydrochloride (0.5 M in anhydrous ethanol, reflux 78°C, 6 hours) produces a bis(imine) ligand in which the thiazole nitrogen and the imine nitrogen create a chelating pocket with a predicted bite angle of 73–76° (DFT-optimized geometry at the B3LYP/6-31G(d) level). The reaction is driven to completion by addition of 2.2 eq of triethyl orthoformate as water scavenger; failure to maintain water content below 300 ppm in the headspace results in imine hydrolysis during crystallization, producing a mono-imine aldehyde impurity that complexes with Cu(II) ions in the subsequent metalation step to generate a catalytically inactive, chloro-bridged dimer. Metallation with palladium(II) acetate (Pd(OAc)₂, 0.95 eq per ligand) in chlorobenzene at 55°C for 3 hours inserts the metal selectively into the N_imi–N_thi cleft, as confirmed by a 15–20 ppm downfield shift of the imine proton resonance in ¹H NMR (400 MHz, DMSO-d₆). The resulting pre-catalyst is employed in Buchwald-Hartwig amination of aryl chlorides at a loading of 0.5 mol% and achieves full conversion of 4-chlorotoluene with morpholine within 2 hours at 80°C (THF, NaO^tBu base), but the thiazole chlorine substituent itself does not undergo oxidative insertion under these conditions as long as the temperature is kept strictly below 95°C. The air-sensitive Pd(II) complex is handled inside a glovebox (O₂ < 5 ppm, H₂O < 1 ppm) and its shelf life as a solid is limited to 10 days at −30°C even under inert atmosphere, as monitored by a discoloration from orange to dark brown that coincides with a drop in catalytic turnover frequency (TOF) from 4,200 h⁻¹ to below 800 h⁻¹.

2-Chloro-1,3-thiazole-5-carboxaldehyde is milled with a polyvinyl alcohol binder and a tetraalkylammonium chloride phase-transfer catalyst in a dry jet-mill (air pressure 7 bar, classifier speed 8,500 rpm) to produce a free-flowing micro-particulate intermediate for a solid-phase peptide synthesis linker that requires DMF-swelling without aldehyde leaching. The presence of the electron-withdrawing chloro group and the heterocyclic nitrogen activates the aldehyde toward nucleophilic attack by a Wang resin that has been pre-loaded with a hydrazine succinoyl spacer, operating at a resin loading of 0.75 mmol/g. Unreacted aldehyde is capped with acetic anhydride/2,6-lutidine, and the loading efficiency is determined by Fmoc release quantification at 301 nm. Any batch with a substitution efficiency below 80% of theoretical is rejected because under-loaded resin leads to truncation sequences that complicate preparative reversed-phase chromatography (C4 column, 50 mm ID) used at 30 cm/min linear velocity. The cured resin is shipped under a controlled temperature of 2–8°C and a specification for residual isopropyl alcohol from the preceding wash step of ≤ 0.08% per ICH Q3C(R8) Class 2 solvent limits.